Eosinophilia : secondary, clonal and idiopathicTEFFERI, Ayalew; PATNAIK, Mrinal M; PARDANANI, Animesh et al.British journal of haematology. 2006, Vol 133, Num 5, pp 468-492, issn 0007-1048, 25 p.Article

Clinical features of hypereosinophilic syndrome : FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroidMIYAZAWA, Keisuke; KAKAZU, Naoki; OHYASHIKI, Kazuma et al.International journal of hematology. 2007, Vol 85, Num 1, pp 5-10, issn 0925-5710, 6 p.Article

Hyperéosinophilie clonale révélée par une infection récurrente à Staphylococcus aureus = Clonal eosinophilia revealed by recurrent Staphylococcus aureus infectionVANDENBOS, F; FIGUEREDO, M; DUMON-GUBENO, M.-C et al.Revue de pneumologie clinique (Paris). 2011, Vol 67, Num 3, pp 167-169, issn 0761-8417, 3 p.Article

FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cellsCRESCENZI, B; CHASE, A; JONES, A. V et al.Leukemia. 2007, Vol 21, Num 3, pp 397-402, issn 0887-6924, 6 p.Article

T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndromeHEIBIG, Grzegorz; WIECZORKIEWICZ, Agata; DZIACZKOWSKA-SUSZEK, Joanna et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1236-1241, issn 0390-6078, 6 p.Article

Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitorsKANEKO, Motoko; ISHIHARA, Kenji; TAKAHASHI, Aki et al.International archives of allergy and immunology. 2007, Vol 143, pp 28-32, issn 1018-2438, 5 p., SUP1Conference Paper

FIP1L1-PDGFRA positive chronic eosinophilic leukemia in Tunisian patients = Leucémie chronique à éosinophiles exprimant FIP1L1-PDGFRA chez des patients tunisiensMENIF, S; OMRI, H; HAFSIA, R et al.Pathologie et biologie. 2007, Vol 55, Num 5, pp 242-245, issn 0369-8114, 4 p.Article

Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctionsSCORE, J; WALZ, C; CROSS, N. C. P et al.Leukemia. 2009, Vol 23, Num 2, pp 332-339, issn 0887-6924, 8 p.Article

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphomaMETZGEROTH, G; WALZ, C; MÜLLER, M. C et al.Leukemia. 2007, Vol 21, Num 6, pp 1183-1188, issn 0887-6924, 6 p.Article

The hypereosinophilic syndromes : current concepts and treatmentsGLEICH, Gerald J; LEIFERMAN, Kristin M.British journal of haematology. 2009, Vol 145, Num 3, pp 271-285, issn 0007-1048, 15 p.Article

Efficacité de l'imatinib dans les syndromes hyperéosinophiliques associés au transcrit FIP1L1-PDGFRA = Efficacy of imatinib in FIP1L1-PDGFRA positive hypereosinophilic syndromeMENIF, S; BEN ROMDHANE, N; HAFSIA, R et al.La Revue de médecine interne (Paris). 2008, Vol 29, Num 1, pp 65-67, issn 0248-8663, 3 p.Article

Successful treatment of myeloid neoplasms associated with PDGFRA rearrangement with imatinib mesylateSUN, Chun-Yan; YU HU; CHU, Zhang-Bo et al.International journal of hematology. 2009, Vol 89, Num 1, pp 66-70, issn 0925-5710, 5 p.Article

A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patientsHELBIG, Grzegorz; STELLA-HOTOWIECKA, Beata; MAJEWSKI, Miroslaw et al.British journal of haematology. 2008, Vol 141, Num 2, pp 200-204, issn 0007-1048, 5 p.Article

Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe hepatotoxicityARAI, Ayako; WEIHUA YAN; WAKABAYASHI, Shihoko et al.International journal of hematology. 2007, Vol 86, Num 3, pp 233-237, issn 0925-5710, 5 p.Article

Hyperéosinophilie essentielle : nouvelle thérapeutique ciblée et nouvelle définition cytologique et moléculaire = Idiopathic hypereosinophilic syndrome : toward a new molecular-targeted therapy and a new cytomorphological and molecular definitionMOLES, M.-P; LANDRY, J; ROCHE-LESTIENNE, C et al.Annales de biologie clinique (Paris). 2005, Vol 63, Num 3, pp 317-322, issn 0003-3898, 6 p.Article

Eosinophilic myeloid disorders: new classification and novel therapeutic strategiesGOTLIB, Jason.Current opinion in hematology. 2010, Vol 17, Num 2, pp 117-124, issn 1065-6251, 8 p.Article

Five years since the discovery of FIP1L1-PDGFRA : what we have learned about the fusion and other molecularly defined eosinophiliasGOTLIB, J; COOLS, J.Leukemia. 2008, Vol 22, Num 11, pp 1999-2010, issn 0887-6924, 12 p.Article

Five years since the discovery of FIP1L1-PDGFRA : what we have learned about the fusion and other molecularly defined eosinophiliasGOTLIB, J; COOLS, J.Leukemia. 2008, Vol 22, issn 0887-6924, P41-P52, HSArticle

KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1l1/PDGFRA-associated chronic eosinophilic leukemia are distinct entitiesMARIC, Irina; ROBYN, Jamie; KIRSHENBAUM, Arnold et al.Journal of allergy and clinical immunology. 2007, Vol 120, Num 3, pp 680-687, issn 0091-6749, 8 p.Article